RBM 39 targeting therapeutic (Recursion Pharmaceuticals)

N/A

Report date: 2024/10/09 17:47:37
NME

Base Information

Drug NameRBM 39 targeting therapeutic (Recursion Pharmaceuticals)
Drug Alias NameREC-1245
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRNA Binding Motif Protein 39 modulators
TargetsRNA Binding Motif Protein 39
Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsLymphoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRecursion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesRecursion Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursOvarian NeoplasmsLymphoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A